Literature DB >> 9830207

Can we deworm this wormy world?

D A Bundy1, N R de Silva.   

Abstract

While programmes such as the Rockefeller campaign were specifically targeted at a particular parasite species, the current trend is towards the simultaneous control of all the major geohelminth species. New, broad-spectrum, low-cost anthelmintics and new understanding of epidemiology have led to more cost-effective and sustainable strategies. The WHO, UNICEF and the World Bank all now support global and regional efforts to achieve control of morbidity from intestinal worms. In this paper, we aim to show what's new in clinical helminthology and what has brought about the great improvement in the success of the new approaches to control.

Mesh:

Substances:

Year:  1998        PMID: 9830207     DOI: 10.1093/oxfordjournals.bmb.a011698

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  16 in total

Review 1.  Drug resistance in human helminths: current situation and lessons from livestock.

Authors:  S Geerts; B Gryseels
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 2.  Helminthic infections.

Authors:  Shally Awasthi; D A P Bundy; Lorenzo Savioli
Journal:  BMJ       Date:  2003-08-23

Review 3.  A successful experience of soil-transmitted helminth control in the Republic of Korea.

Authors:  Sung-Tae Hong; Jong-Yil Chai; Min-Ho Choi; Sun Huh; Han-Jong Rim; Soon-Hyung Lee
Journal:  Korean J Parasitol       Date:  2006-09       Impact factor: 1.341

Review 4.  Monoaminergic signaling as a target for anthelmintic drug discovery: receptor conservation among the free-living and parasitic nematodes.

Authors:  Richard Komuniecki; Wen Jing Law; Aaron Jex; Peter Geldhof; John Gray; Bruce Bamber; Robin B Gasser
Journal:  Mol Biochem Parasitol       Date:  2012-02-11       Impact factor: 1.759

5.  Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults.

Authors:  Kayvon Modjarrad; Isaac Zulu; David T Redden; Lungowe Njobvu; H Clifford Lane; Zvi Bentwich; Sten H Vermund
Journal:  J Infect Dis       Date:  2005-08-25       Impact factor: 5.226

6.  Anthelmintic activity of KSI-4088 against Caenorhabditis elegans.

Authors:  Kusuma Kaewintajuk; Pyo Yun Cho; Sung Yeon Kim; Eun Sil Lee; Hyeon-Kyu Lee; Eun Bok Choi; Hyun Park
Journal:  Parasitol Res       Date:  2010-03-23       Impact factor: 2.289

Review 7.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Reductions in the prevalence and incidence of geohelminth infections following a city-wide sanitation program in a Brazilian Urban Centre.

Authors:  Luciene Maura Mascarini-Serra; Carlos A Telles; Matildes S Prado; Sheila Alvim Mattos; Agostino Strina; Neuza M Alcantara-Neves; Mauricio L Barreto
Journal:  PLoS Negl Trop Dis       Date:  2010-02-02

9.  Which new approaches to tackling neglected tropical diseases show promise?

Authors:  Jerry M Spiegel; Shafik Dharamsi; Kishor M Wasan; Annalee Yassi; Burton Singer; Peter J Hotez; Christy Hanson; Donald A P Bundy
Journal:  PLoS Med       Date:  2010-05-18       Impact factor: 11.069

10.  An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria.

Authors:  S Omura; H Miyadera; H Ui; K Shiomi; Y Yamaguchi; R Masuma; T Nagamitsu; D Takano; T Sunazuka; A Harder; H Kölbl; M Namikoshi; H Miyoshi; K Sakamoto; K Kita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.